Thiazolidinediones (rosiglitazone, pioglitazone) are oral insulin-sensitizing medications used in type 2 diabetes mellitus that can reduce glucose with a minimal risk of hypoglycemia and potential anti-atherosclerotic effects. Here, INS is linked to type 2 diabetes mellitus.